~~<i id='441D003820'><strike id='441D003820'><tt id='441D003820'><pre id='441D003820'></pre></tt></strike></i>~~

Home» explore» Wikipedia

Wikipedia

author：fashion 2025-09-27 12:02:46 Page View：7

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food makers tried to stack nutrition panel with preferred experts
Next article： Anesthesiologist group: stop taking Ozempic before surgery

leisure time

Walensky prepares to leave CDC — and Congress — behind

OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

Regeneron agrees to White House price limits on anti

RegeneronagreedtopricelimitsforanewCovid-19drugthatwillbedevelopedinpartnershipwiththeDepartmentofHe

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

Lilly’s weekly insulin works as well as daily products, new studies show

AdobeEliLillyreportedThursdaythatitsexperimentalweeklyinsulinworkedaswellasdailybasalinsulinproducts

WSS

Wikipedia

Wikipedia

knowledge

leisure time

Lilly’s weekly insulin works as well as daily products, new studies show